Health and Healthcare
What This FDA Approval Means for STAAR Surgical
Published:
Last Updated:
STAAR Surgical Co. (NASDAQ: STAA) shares made a handy gain on Friday after the firm announced a key approval by the U.S. Food and Drug Administration (FDA).
The FDA granted the approval of the PMA Supplement for the Visian Toric Implantable Collamer Lens (ICL) for the correction of myopia with astigmatism.
Overall, this approval represents a meaningful expansion of the ICL product line for the correction of refractive error in patients with both myopia and astigmatism, which are common conditions in the United States. Astigmatism affects roughly 30% of the population.
Patients have described ICL surgery as “life-changing” or wished they had opted for the surgery sooner. The ICL in both spherical and toric designs has been associated with significant improvements in quality of life. The approval of the Visian Toric ICL is also an important step toward the future availability of advanced ICL models in the United States, such as the EVO/EVO+ Toric ICL.
Caren Mason, president and CEO, commented:
FDA’s approval of STAAR’s Visian Toric ICL in the U.S. provides an exciting treatment option for myopic patients with astigmatism in search of visual freedom. We are thrilled to be able to offer this lens in the United States and look forward to officially making the Visian Toric ICL available to U.S. surgeons for their patients on November 1st, 2018.
Shares of STAAR were last seen up about 3% at $52.15, with a consensus analyst price target of $49.00 and a 52-week range of $10.75 to $51.40.
24/7 Wall St.The #1 Thing to Do Before You Claim Social Security (Sponsor)
Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.
A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.
Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
